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Quality assurance in the modern clinical laborato-
ry is evidenced through the complementary pro-
cesses of internal quality control and external 
quality assessment, also known as proficiency test-
ing. By these processes and the achievement of 
accreditation to international (e.g. ISO) standards, 
the laboratory is able to demonstrate its compe-
tence to the users of its services, i.e. the clinicians 
and the patients they care for, who have an expec-
tation that the results of diagnostic testing and 
monitoring of treatment are correct, comparable 
and fit-for-purpose within the scope of the service, 
wherever they are performed.
External quality assessment (EQA) was first intro-
duced in the 1950s and 1960s in response to the 
growing role of laboratory testing as an essential 
part of disease diagnosis and management and an 
awareness of the extent of variability in results 
from one laboratory to another, for example as de-
scribed by Mitchell Lewis following his initial inter-
laboratory trials in the UK (1). The earliest EQA ser-
vices were developed by committed and enthusi-
astic individual pathologists and laboratory scien-
tists, often with limited resources and alongside 
their day-to-day clinical services; at the time, it was 
thought that harmonisation of performance 
would be achieved by the operation of a short-
term programme of inter-laboratory testing 
rounds. The aim of this Special issue of Biochemia 
Medica is to provide a comprehensive overview of 
the latest developments in EQA and keep our 
readers up-to-date with the role and significance 
of EQA in laboratory medicine and its future direc-
tions taking into account the changing demands 
of the profession and the evolution of analytical 
technology. In this issue we provide a number of 
outstanding contributions by internationally rec-
ognised experts in the field, who have been invit-
ed to address various issues and different aspects 
of EQA in the modern time, almost seven decades 
after its very origins.
EQA is nowadays available to some degree in all 
developed healthcare systems and is a means to 
improving the quality of laboratory performance 
(2,3). Participation in EQA may be voluntary, al-
though a prerequisite for accreditation, or may be 
mandatory, for licensing. For example, in the USA, 
the necessity for EQA (or PT) is enshrined in the 
Clinical Laboratory Improvement Act of 1988 (CLIA 
‘88) and in Germany, laboratories have to fulfil the 
RiliBÄK requirements. The provision of contempo-
rary EQA services still relies on the commitment 
and expertise of individuals; however, the opera-
tion of a large, multi-disciplinary EQA programme 
as a complex, clinical technical service requires a 
range of skills and expertise including statistics, in-
formation technology, batch production proce-
dures, logistics and distribution, in addition to ex-
pert subject knowledge.  
The World Health Organisation updated and re-is-
sued its manual for the establishment and opera-
tion of an EQA programme in 2016, providing 
comprehensive guidance on the strategies and re-
sponsibilities for EQA operation, and the interna-
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tional standards ISO17043:2010 Conformity assess-
ment – General requirements for proficiency test-
ing and ISO13528:2015 Statistical methods for use 
in proficiency testing by interlaboratory compari-
son give details of the quality standards directly 
applicable to EQA providers (4). The ISO standards 
are generic documents, intended for EQA and pro-
ficiency testing in all sectors, not just medical lab-
oratories. Although the importance of the role of 
EQA is recognised by national and international 
professional laboratory medicine societies, the Eu-
ropean Quality Assurance in Laboratory Medicine 
(EQALM) organisation is the preeminent profes-
sional association dedicated solely to EQA provi-
sion. EQALM’s essential and growing role is re-
viewed in the article, “An overview of the European 
Organization for External Quality Assurance Provid-
ers in Laboratory Medicine (EQALM)” (5). The respon-
sibility for the choice of an appropriate EQA pro-
vider organisation lies with the laboratory and di-
versity in the scope of EQA provision is needed to 
match the diversity of testing services. Organisa-
tions such as EQALM give EQA providers the op-
portunity to share best practice and learn from the 
experience of others, with the objective that an 
appropriate and effective performance standard is 
applied to laboratory assessment, wherever the 
test may be undertaken. Harmonisation and 
standardisation of laboratory medicine practice is 
not only desirable as part of good patient care but 
becomes essential when patients’ samples may be 
examined in different locations or by different 
healthcare providers. Graham Jones reviews the 
impact and influence of EQA in laboratory medi-
cine harmonisation in his article, “The role of EQA in 
harmonisation in laboratory medicine – a global ef-
fort” (6).
EQA of the analytical phase of diagnostic testing 
entails the EQA provider distributing a sample or 
other artefact of known but undisclosed content 
to the participating laboratories or testing sites, 
which are usually medical laboratories but are in-
creasingly to be found in ‘point of care’ situations, 
such as the ward or operating theatre, in clinics or 
doctors’ surgeries and in the community. The sites 
test the material as if it were a patient’s sample 
and report their results to the EQA provider for 
statistical analysis. By comparison with minimum 
acceptable performance limits, the EQA provider 
can identify laboratories, methods, kits or reagents 
with out-of-consensus results and ensure that ap-
propriate corrective action is taken, either by the 
laboratory or some other regulatory agency. EQA 
for point-of-care testing (POCT), especially when 
outside the hospital environment, has different re-
quirements from testing provided by laboratory 
professionals, although immediate clinical deci-
sions may be made according to the results. EQA 
for POCT must be robust, easy to operate and fit 
for the environment in which the testing takes 
place, as is reviewed by Anne Stavelin in the arti-
cle, “Essential aspects of external quality assurance 
for point-of-care testing” (7).
A major challenge for provision of EQA in haema-
tology is the choice of assay material for automat-
ed cell counting and the options are reviewed by 
Barbara De la Salle in her article “Survey material 
choices in haematology EQA: a confounding factor in 
automated counting performance assessment” (8). 
There is no ideal assay material for automated cell 
counting because of the inherent conflict between 
material commutability and stability and the lack 
of certified reference materials and methods to 
which results can be traced. Blood cells are inher-
ently unstable and deteriorate within hours of col-
lection, especially in terms of cell morphology and 
platelet counting. Methods of cell stabilisation re-
sult in changes in the cell membrane, which affect 
how the cells react in the different cell counting 
technologies. These technologies are changing 
rapidly, especially with the introduction of ‘black 
box’ technologies in POCT, designed to work with 
fresh, capillary blood.
The concept of using statistical analysis for quality 
control as part of the production process was de-
veloped in the in the decades between the first 
and second world wars with the introduction of 
mass production methods in industry, where con-
trol of the quality of the output through the moni-
toring and sampling of an automated production 
line rather than the individual attention of a skilled 
craftsman became standard practice. The applica-
tion of similar quality control methods were ap-
plied in the clinical laboratory alongside the intro-
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duction of automated testing, with the develop-
ment of internal quality control (IQC) and EQA pro-
cedures. The standard for methods for statistical 
analysis in EQA are described in ISO 13528:2015 
but the standard can be applied in a number of 
forms. Although the principles of statistical use in 
EQA is relatively straightforward, requiring the 
definition of a target value and statistical perfor-
mance limits based on distance from the target, 
there are a number of statistical processes and ma-
nipulations involved that require some expert 
knowledge on the part of the EQA provider and 
translation into an intelligible format for partici-
pants’ reports. Wim Coucke’s article, “Demystifying 
EQA statistics and reports” reviews the application 
of the available statistical approaches and these is-
sues are complemented by Kristensen’s article, “In-
terpretation of EQA results and EQA-based trouble 
shooting”, which describes a ‘diagnostic’ approach 
for identifying the possible causes of an out-of-
consensus EQA result, drilling down to separate 
‘true’ performance problems from those relating 
to, for example, specimen quality or data entry 
(9,10).
Quality improvement is not static and quality 
monitoring has now expanded to cover the total 
testing process, including the pre- and post-ana-
lytical stages, where the majority of errors in ana-
lytical testing occur (11). There are many points in 
this pathway, from selection of test, identification 
of the patient and specimen collection through to 
timely reporting to the correct physician, where 
errors that affect the outcome of the testing may 
occur. The laboratory is required to take responsi-
bility for identifying and controlling these errors 
and to demonstrate the effectiveness of their pro-
cedures for this. Three models for EQA of the pre- 
and post-analytical phases have been previously 
described: the external assessment of written pro-
cedures (type I), the distribution of specimens with 
pre-analytical errors, such as labelling errors or 
haemolysis (type II) and the monitoring of the inci-
dence adverse events in the pre- and post-analyti-
cal phases (type III) (12). The Royal College of Pa-
thologists in Australasia Quality Assurance Pro-
gramme (RCPAQAP) has one of the most well es-
tablished type III model programmes, reviewed by 
Badrick and his colleagues in their article entitled 
“External Quality Assessment beyond the analytical 
phase: an Australian perspective” (13). The experi-
ence of other providers of pre- and post-analytical 
phase EQA are reviewed by Nikolac and colleagues 
in their article about the preanalytical external 
quality assessment organized by the Croatian So-
ciety of Medical Biochemistry and Laboratory 
Medicine and Lenicek Krleza et al. in their article 
on the post-analytical External quality assessment 
of laboratory testing in medical laboratories in 
Croatia (14,15). 
The transition of EQA theory into practice is a 
daunting task and EQA provider organisations rely 
on the sharing of best practice to anticipate and 
meet the demands of the rapidly changing field of 
diagnostic testing and the requirement for service 
harmonisation in modern healthcare. In addition 
to the review areas of new developments and best 
practice in EQA, this special edition shares the ex-
periences of establishing and developing effective 
EQA services in a range of different healthcare sys-
tems. The challenge of EQA provision in resource 
limited countries and the implementation of re-
gional proficiency testing in East Africa, is exten-
sively and comprehensively reviewed by Jane 
Carter, Stephen Munene and co-workers. Their 
work represents a truly global summary of the im-
pact and influence of EQA in a challenging envi-
ronment where allocation of resources to labora-
tory testing is unfortunately still of very low priori-
ty (16,17). Marcos Fleury gives an excellent review 
of general EQA provision in Brazil in his article, “Im-
plementation of the External Quality Assessment Pro-
gram in Brazil” and Jasna Lenicek Krleza provides a 
similar insight to the challenges experienced in 
Croatia in “External Quality Assessment in Croatia: 
problems, challenges, and specific circumstances” 
(18,19). The experience of providing EQA in spe-
cialist areas is highlighted by Zhang et al. in the ar-
ticle, “Proficiency testing of maternal serum prenatal 
screening in second trimester in China, 2015”, and by 
Aralica and Lenicek Krleza in the article on sweat-
testing EQA in Croatia, “Evaluating performance in 
sweat testing in medical biochemistry laboratories in 
Croatia” (20,21).
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The variety on topics discussed in the special edi-
tion shows the relevance of effective EQA as a part 
of the total quality management of the laboratory. 
This is relevant not just for medical laboratories 
but even more relevant for the benefit of the pa-
tients they serve. We wish to thank the authors for 
their efforts in preparing their contributions and 
for making this Special issue so comprehensive 
and valuable reading material. It has been an im-
mense privilege for us to work with them and take 
the advantage of their broad experience and wide 
knowledge. We hope that you will enjoy reading 
articles within this issue, as much as we have en-
joyed in creating it, from its original concept to the 
final outcome. 
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